baber/WOPTO huggingface dataset:
Patent CA-2287209-A1 (CA)
Title: Solar battery module for photoelectrolytic device and photoelectrolytic device
Inventor: NAKATA JOSUKE
IPC: H01L31/04
Filed: 1998-01-23
Abstract: Partition member 34 is provided, which partitions the interior of glass container 31 into reduction reaction chamber 32 and oxidation reaction chamber 33 and which is made of a polymer electrolyte that conducts hydrogen ions; solar battery modules 35 are mounted on this partition member 34, for example in a matrix arrangement of five rows and three columns;  a solar battery module 35 has a photocell array (photoelectromotive force: 2.0-2.4 V) consisting of four spherical solar battery elements (photoelectromotive force: 0.5-0.6 V) connected in series, anode 46, and cathode 48; solar battery modules 35 are mounted on partition member 34 so that anode 46 is in contact with the electrolyte of oxidation reaction chamber 33 and cathode 48 is in contact with the electrolyte of reduction reaction chamber 32; sunlight is shined an solar battery modules 35, and the photoelectromotive force electrolyzes the water and produces hydrogen gas from cathode 48 and oxygen gas from anode 46.
Patent CA-2287430-A1 (CA)
Title: Ink additives
Inventor: COHEN EITAN
IPC: C09D11/00
Filed: 1998-04-15
Abstract: An additive for a pigment based ink-jet printing composition which is used in conjunction with a printing head that comprises metallic components, is disclosed. The additive comprises a cationic component and an anionic component, and characterized in that the cationic component is a cationic surfactant. Preferred additives are those where the cationic component is C10-22alkyl trimethyl ammonium. Pigment-based ink-jet printing compositions comprising these additive are also described.
Patent CA-2292122-A1 (CA)
Title: Floor care machine
Inventor: STEIN THOMAS
IPC: B24B7/18
Filed: 1999-12-13
Abstract: A floor care machine realized in the form of a floor polishing machine contains a driven pad, the height of which pad can be adjusted automatically to adjust the application pressure to take the characteristics of the floor into consideration. For this purpose, between the driving element and the driven element, there is a transmission element which forms a torque regulator. For this purpose, the driven element can be rotated with respect to the driving element opposite to the working direction of rotation and can also be displaced axially, whereby the transmission element with a clamping element automatically regulates the displacement and rotation, thereby acting as a torque regulator to regulate the height of the pad with respect to the floor as a function of the torque.
Patent CA-2292399-A1 (CA)
Title: Process for the preparation of substituted keto-enamines
Inventor: MENZIA JEROME A
IPC: C07C225/16
Filed: 1998-05-19
Abstract: The present invention discloses a process for the preparation of a substantially pure compound having formula (4). The process comprises the step of reacting an enolate having formula (A) with a Grignard reagent. The enolate salt is formed in situ from the reaction of a protected ester wherein M is an alkali metal. R6 and R7 are each hydrogen or are independently selected from (i) wherein Ra and Rb are independently selected from hydrogen, lower alkyl and phenyl and Rc, Rd and Re are independently selected from hydrogen, lower alkyl, trifluoromethyl, alkoxy, halo and phenyl; and (ii) wherein the naphthyl ring is unsubstituted or substituted with one, two or three substituents independently selected from lower alkyl, trifluoromethyl, alkoxy and halo. Alternatively, R6 is as defined above and R7 is R12OC(O)- wherein R12 is benzyl; or R6 and R7 taken together with the nitrogen atom to which they are bonded form (B) or (C), wherein Rf, Rg, Rh and Ri are independently selected from hydrogen, lower alkyl, alkoxy, halogen and trifluoromethyl.
Patent CA-2294457-A1 (CA)
Title: Pharmaceutical composition for application to mucosa
Inventor: NISHIBE YOSHIHISA
IPC: A61P37/08
Filed: 1999-04-21
Abstract: The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water--low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high permeability to the blood at the mucosa. The present invention further provides a pharmaceutical composition for application to the mucosa comprising a hemostatic agent and a medicament. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to permeability and retentivity at the mucosa.
Patent CA-2297602-A1 (CA)
Title: Electron source, and image-forming apparatus and method of driving the same
Inventor: YAMAGUCHI EIJI
IPC: G09F9/30
Filed: 1993-12-24
Abstract: An electron source emits electrons as a function of input signals. The electron source comprises a substrate, a matrix of wires having m row wires and n column wires laid on the substrate with an insulator layer interposed therebetween, and a plurality of surface-conduction electron-emitting devices each having a pair of electrodes and a thin film including an electron emitting region and arranged between the electrodes. The electron-emitting devices are so arranged as to form a matrix with the electrodes connected to the respective row and column wires. The electron source further comprises selection means for selecting a row of the plurality of surface-conduction electron-emitting devices, and modulation means for generating modulation signals according to input signals and applying them to the surface-conduction electron-emitting devices selected by the selection means.
Patent CA-2301222-A1 (CA)
Inventor: SUONVIERI JUKKA
IPC: H04L12/24
Filed: 1998-08-31
Abstract: L'invention concerne l'utilisation d'au moins deux modems situés du côté du système de gestion de réseau. On met en application au moins un de ces modems uniquement pour des connexions initialisées par le système de gestion de réseau. On utilise au moins un autre modem uniquement pour des connexions initialisées par tout groupe ou par un groupe d'éléments de réseau commandés par le système de gestion de réseau. Le nombre de modems mis en service pour des connexions initialisées par le système de gestion de réseau peut être supérieur à un, ce qui permet au système de gestion de réseau d'initialiser des connexions simultanées vers plus d'un élément de réseau. De même, on peut affecter plus d'un modem à des connexions initialisées par les éléments de réseau.
Patent CA-2301987-A1 (CA)
Inventor: AIZAWA MASATOSHI
IPC: H04L12/54
Filed: 2000-03-22
Abstract: There is provided a communication terminal which does not consume electrical power unreasonably and surely notifies to a user when information is set to a terminal or setting of terminal is updated depending on the information transmitted, wherein when the setting update message addressed to own terminal is received, a control circuit sets or updates terminal setting information of EEPROM and stores the user notification text (notification information) of setting update message to RAM and also displays a mark for indicating the storing of notification information to RAM on the display area of LCD.
Patent CA-2302645-A1 (CA)
Inventor: ROUSSET ERIC
IPC: D21H19/82
Filed: 1998-09-01
Abstract: The invention concerns paper or cardboard with improved printability, designed to be printed with gravure or flexographic printing, consisting of a base fabric coated with at least a standard surface coat, a coating of a composition based on specific pigments for improving the standard surface coating contact with printing ink, said composition containing at least a specific pigment selected in the group including silicon, precipitate calcium carbonate (PCC), calcined kaolin on their own or mixed, and being deposited on the base fabric in the proportion of not more than five grams per square meter (5g/m<2>). The invention also concerns a method for making said paper or cardboard.
Patent CA-2303542-A1 (CA)
Title: Methode de certification de cles publiques servant a signer l'empreinte d'affranchissement et empreinte d'affranchissement signee
Inventor: VANSTONE SCOTT A
IPC: H04L9/32
Filed: 2000-03-30
Abstract: Procédé de certification de la clé publique d'un compteur postal numérique utilisant un système de chiffrement par clé publique, par une autorité de certification. Une station de certification et une station d'utilisateur, ou un compteur postal numérique échangent des informations et la station d'utilisateur télécharge, ou le compteur dérive, une clé publique à partir des informations échangées. La station de certification publie également des informations associées et leur clé publique. Un tiers peut dériver la clé publique correspondant à la clé privée du compteur en agissant sur les informations publiées avec la clé publique de la station de certification.
Patent CA-2307750-A1 (CA)
Inventor: HUTTER PETER S
IPC: B01F7/00
Filed: 1998-10-23
Abstract: L'invention porte sur un appareil de malaxage sous vide de matériaux réactifs composites comprenant une cuve (24) de malaxage dimensionnée pour contenir le matériau réactif (92), et un agitateur malaxeur comportant et des pales rigides (60) et des pales souples (58). Les pales rigides (60) qui ne fléchissent pratiquement pas pendant le malaxage ont une action tranchante, tandis que les pales souples (58) fléchissent et pétrissent le mélange. L'action combinée de ces pales et du vide (20) assure un mélange parfait dont sont exclues les bulles captives. Le mélange peut être directement versé depuis la cuve. L'appareil peut traiter des matériaux visqueux tels que du ciment d'os.
Patent CA-2308429-A1 (CA)
Title: Modular health-care information management system utilizing reusable software objects
Inventor: DEBUSK BRIAN C
IPC: G16H40/20
Filed: 1998-11-05
Abstract: Disclosed is a health-care information management system that utilizes modular and reusable software objects to allow for user configuration. The disclosed information management system allows for the creation by the user of software objects representative of specific events and resources which will occur or be utilized during the provision of health-care to patients. These user configured software modules then allow the user to track the provision of health-care, the utilization of resources during the provision of health-care, the allocation of resources to perform medical procedures and identify opportunities for enhancing efficiencies in the provision of health-care services. In one embodiment, the system allows for the user to create, manage and maintain software modules (202) representing specific clinical pathways to be performed in a health-care institution. The user creates these modules using user configurable software objects that function to represent containers (204), resources (206) and data.
Patent CA-2311121-A1 (CA)
Title: Unite de commande a distance
Inventor: SORENSEN PER HASSEL
IPC: G08C19/28
Filed: 1998-12-07
Abstract: L'invention concerne une unité de commande à distance permettant de commander une sélection sur un appareil électronique. L'unité de commande à distance comprend deux rangées parallèles de boutons de commande (4). Un cylindre de commande (3) est disposé latéralement par rapport à la rangée de boutons de commande, le cylindre étant encastré et parallèle aux boutons de commande (4). A la surface du cylindre de commande (3) on peut voir, par une cavité du panneau de commande, des descriptions (2a - 2i) fixes ou remplaçables des fonctions de tous les boutons de commande (4) placés axialement pour chaque appareil à commander. On peut faire tourner le cylindre de commande (3) autour de son axe, l'utilisateur pouvant ainsi sélectionner entre plusieurs séries de descriptions fonctionnelles (2a - 2i) des boutons de commande. Lorsqu'une série quelconque (2b) de descriptions fonctionnelles est visible et centralisée par rapport aux boutons de commande (4), le cylindre de commande se trouve mécaniquement dans une position plus stable que lorsque les descriptions fonctionnelles (2b) ne sont visibles qu'en partie, le cylindre (3) étant verrouillé dans la position stable au moyen d'un verrou (13) mécanique à ressort.
Patent CA-2313743-A1 (CA)
Inventor: SUZUKI HIRONORI
IPC: H01T4/04
Filed: 2000-07-07
Abstract: An arrester comprises at least one of non-linear resistor mainly consisting of a zinc oxide, terminal electrodes disposed to both end portions of the non-linear resistor to be electrically conductive so as to construct an internal element, an insulative woven fabric impregnated with an insulation resin which is hardened by being heated, the insulative woven fabric being applied so as to surround the internal element, and a polymer resin integrally molded to the internal element surrounded by the insulative woven fabric. The arrester is manufactured by conductively joining the terminal electrodes to both end portions of the non-linear resistor, covering a surrounding of the internal element with an insulative woven, fabric, arranging the integrated internal element in a mold, injecting a polymer resin mixed with a main liquid, a hardening agent and a coloring agent into the mold, and hardening the polymer resin in the mold so as to form an insulator.
Patent CA-2314578-A1 (CA)
Title: A process for inhibiting the emission of hydrogen sulfide and/or mercaptans from sulfurized organic compounds
Inventor: FESSENBECKER ACHIM
IPC: C07C321/04
Filed: 2000-07-26
Abstract: The present invention provides a process for inhibiting the emission of hydrogen sulfide and/or mercaptans from sulfurized organic compounds, which generally contain a high proportion of sulfur by treating the sulfurized organic compounds with organic hydroperoxides.
Patent CA-2317599-A1 (CA)
Inventor: DA SILVA VALERIA L
IPC: H04B10/2563
Filed: 1999-01-07
Abstract: La présente invention concerne la réduction de mélange à quatre ondes de signaux transmis dans un système (fig. 1) de transmission d'ondes lumineuses, obtenue au moyen (1) de groupage des signaux en paires de fréquences voisines, et (2) d'augmentation de la fréquence de chaque autre paire d'une quantité fixe, cette quantité fixe étant inférieure à la variation permise par la grille de l'UIT.
Patent CA-2319505-A1 (CA)
Title: Two phase titanium aluminide alloy
Inventor: LIU C T
IPC: C22F1/18
Filed: 1999-02-02
Abstract: A two phase titanium aluminide alloy having a lamellar microstructure with little intercolony structures. The alloy can include fine particles such as boride particles at colony boundaries and/or grain boundary equiaxed structures. The alloy can include alloying additions such as <= 10 at % W, Nb and/or Mo. The alloy can be free of Cr, V, Mn, Cu and/or Ni and can include, in atomic %, 45 to 55 % Ti, 40 to 50 % Al, 1 to 5 % Nb, 0.3 to 2 % W, up to 1% Mo and 0.1 to 0.3 % B. In weight %, the alloy can include 57 to 60 % Ti, 30 to 32 %  Al,4 to 9 % Nb,up to 2 % Mo, 2 to 8 % W and 0.02 to 0.08 % B.
Patent CA-2321298-A1 (CA)
Title: Diagnostic test protocol in an implantable medical device
Inventor: VANDEGRIFF JOSEPH W
IPC: A61N1/37
Filed: 1999-02-17
Abstract: An implantable medical device electrically stimulates the heart to beat and senses electrical activity in the heart. The medical device generally includes a processor, a plurality of electrodes, and a sense amplifier. The medical device is capable of performing a variety of diagnostic tests, such as a sensing test in which a suitable sensitivity setting is computed for the sense amplifier. An external programmer is also provided to initiate the diagnostic tests. The programmer transmits a start signal to the implantable medical device and the medical device's processor initiates the diagnostic test specified by the programmer via the start signal. The implantable device is capable of completing the diagnostic test without further communication from the programmer or may initiate communication with the programmer during a refractory period in which signals from the programmer will not interfere with the diagnostic test. In the latter case, the programmer responds before the refractory period ends.
Patent CA-2321350-A1 (CA)
Inventor: MAUFFREY GUY
IPC: A47J37/08
Filed: 2000-10-04
Abstract: A toaster is disclosed including a main frame with a toasting compartment including an electrical resistance heater, a carriage mounted for reciprocation within the toasting compartment so that the bread product to be toasted can be loaded when the carriage is in an upper position and the bread product can be toasted when the carriage is in the lower position, an electromagnet for holding the carriage in the lower position, and a safety assembly for interrupting the supply of electricity to the electrical resistance heater at the end of a toasting cycle independent of the position of the carriage with the subassembly and including a lock to lock the carriage in the lower position, an armature for carrying the lock mounted adjacent to the electromagnet, and a resilient contact to establish electrical contact with the electrical resistance heater when the assembly is in the active position.
Patent CA-2324810-A1 (CA)
Inventor: RANDOLPH BRUCE B
IPC: C10G69/12
Filed: 2000-10-31
Abstract: A novel integrated olefin processing scheme is provided where olefins and paraffins are processed to produce high octane gasoline blending components. The integrated process involves the processing of olefins by hydroisomerization to produce a hydroisomerate stream which is subsequently alkylated in an alkylation process with branched chain paraffin hydrocarbons to produce an alkylate product. The alkylate product can further be separated into various fractions, including propane, n-butane, i-butane and a C5+ alkylate stream. The C5+ alkylate stream can be separated into an i-pentane stream and a deisopentanized C5+ alkylate stream.
Patent CA-2326406-A1 (CA)
Inventor: GAJEWSKI THOMAS F
IPC: A61K38/00
Filed: 1999-04-23
Abstract: The invention provides methods of inducing the production of cytolytic T  lymphocytes directed against malignancy or infectious agent by a mammal and treating such disease such that deleterious side effects are minimized and treatment of metastatic melanomas are surprisingly and dramatically improved.
Patent CA-2329096-A1 (CA)
Title: Keyboard clamp tray assembly
Inventor: WISNIEWSKI MICHAEL G
IPC: G06F3/039
Filed: 2000-12-20
Abstract: An assembly for mounting a keyboard includes first and second members each having a clamping device, and mourning means for mounting the members for converging/diverging movements for removably placing the clamping devices in clamping engagement with a keyboard when placed therebetween. The mounting means includes a first part fixed to one of the members, a second part fixed to the other of the members, wherein the first part defines an opening for slidably supporting the second part, and thus the other of the members for converging/diverging movements, a locking device for releasably restraining manually induced diverging movement, while freely permitting convergent movement, of the members, and means for adjustably supporting an auxiliary art device support, such as a mouse support.
Patent CA-2329130-A1 (CA)
Title: Compositions and methods for non-parenteral delivery of oligonucleotides
Inventor: COOK PHILLIP D
IPC: A61K38/00
Filed: 1999-05-20
Abstract: The present invention relates to compositions and methods which enhance the local and systemic uptake and delivery of oligonucleotides and nucleic acids via non-parenteral routes of administration. Pharmaceutical compositions comprising oligonucleotides disclosed herein include, for systemic delivery, emulsion and microemulsion formulations for a variety of applications and oral dosage formulations. It has also suprisingly been discovered that oligonucleotides may be locally delivered to colonic sites be rectal enemas and suppositories in simple solutions, e.g., neat or in saline. Such pharmaceutical compositions of olignonucleotides may further include one or more penetration enhancers for the transport of oligonucleotides and other nucleic acids across mucosal membranes. The compositions and methods of the invention are utilized to effect the oral, buccal, rectal or vaginal administration of an antisense oligonucleotide to an animal in order to modulate the expression of a gene in the animal for investigative, therapeutic, palliative or prophylactic purposes.
Patent CA-2329940-A1 (CA)
Title: Traitement du myelome multiple au moyen d'anticorps du cd38 obtenus par genie genetique
Inventor: DONOVAN KATHLEEN A
IPC: A61K48/00
Filed: 1999-06-04
Abstract: La présente invention concerne un polypeptide de fusion renfermant un anticorps ou un fragment de cet anticorps. Ce polypeptide de fusion joue un rôle utile dans des compositions pharmaceutiques destinées au traitement du myélome multiple.
Patent CA-2331610-A1 (CA)
Inventor: LAWANDY NABIL M
IPC: H01S3/08
Filed: 1999-05-13
Abstract: An elongated structure includes a core (D), one or more gain medium layers disposed about said core for providing a plurality of characteristic emission wavelengths (.lambda.1, .lambda.2, .lambda.3), and a growth matrix of functionalized support suitable for the synthesis therein or thereon of a chemical compound. Other embodiments can be spherical, or planar with a plurality of optical gain medium dots, each providing a different emission wavelength. Also disclosed is a technique for selectively locating micro-laser beads of interest, and then aiming a laser source at the bead(s) of interest in order to interrogate the optically encoded identification information. Also disclosed is a bead that includes a functionalized support, and that further includes a gain medium coupled to a structure that supports the creation of at least one mode for electromagnetic radiation, and/or which has a dimension or length in one or more directions for producing and supporting amplified spontaneous emission (ASE).
Patent CA-2332172-A1 (CA)
Inventor: STASAITIS LINAS R
IPC: A61Q5/10
Filed: 2001-01-25
Abstract: 1-(2,5-Diaminophenyl)ethanol useful as a primary intermediate for the oxidative dyeing of hair.
Patent CA-2334302-A1 (CA)
Title: System and methods for facilitating a commercial transaction
Inventor: SANCHEZ JUAN PABLO
IPC: G06Q40/02
Filed: 2001-02-06
Abstract: A financing method incorporating a new use of at least one negotiable instrument which is utilized by a buyer (B), a seller (S), and a financial institution (FI), said method comprising the steps of the financial institution concluding an agreement defining the rights and obligations between each set party when the buyer agrees to at least utilize a negotiable instrument recognizable by the financial institution; the buyer and a supplier concluding a transaction where by the supplier supplies goods or services to the buyer for an invoiced amount; the buyer tendering to the supplier a postdated negotiable instrument in the amount of the invoiced value; the supplier presenting the financial institution with the postdated negotiable instrument; the financial institution immediately remitting to the supplier the tendered amount of the negotiable instrument minus a predetermined percentage; the financial institution depositing the negotiable instrument on the due date there for collection in the normal banking system in the same manner as any cheque drawn the buyer's account.